​

Funding Round

Series C - Apnimed

Series C - Apnimed

Investment Firm

Overview

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

Announced Date

May 04, 2022

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management is a early_stage_venture and late_stage_venture and post_ipo firm.

Participant Investors

4

Investor Name
Participant InvestorAlpha Wave Ventures
Participant InvestorAlpha Wave Global
Participant InvestorTao Capital Partners
Participant InvestorSectoral Asset Management

Round Details and Background

Apnimed raised $62500000 on 2022-05-04 in Series C

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 31, 2020
Venture Round - Apnimed
-15.0M
Mar 25, 2021
Series B - Apnimed
2-25.0M
May 04, 2022
Series C - Apnimed
5-62.5M
Dec 23, 2022
Series C - Apnimed
4-79.7M

Recent Activity

There is no recent news or activity for this profile.